(1.20%) 5 070.55 points
(0.69%) 38 504 points
(1.59%) 15 697 points
(0.05%) $83.40
(-0.11%) $1.810
(-0.17%) $2 338.10
(0.34%) $27.46
(0.15%) $924.20
(-0.01%) $0.934
(-0.12%) $10.89
(-0.03%) $0.803
(0.02%) $93.21
Live Chart Being Loaded With Signals
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland...
Stats | |
---|---|
Today's Volume | 1 100.00 |
Average Volume | 4 645.00 |
Market Cap | 258.46M |
EPS | $0 ( 2024-03-06 ) |
Next earnings date | ( $-0.380 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -5.69 |
ATR14 | $0.103 (0.97%) |
PROFOUND MEDICAL CORP Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
PROFOUND MEDICAL CORP Financials
Annual | 2023 |
Revenue: | $7.20M |
Gross Profit: | $4.38M (60.87 %) |
EPS: | $-1.350 |
Q4 | 2023 |
Revenue: | $2.01M |
Gross Profit: | $1.06M (52.71 %) |
EPS: | $0 |
Q3 | 2023 |
Revenue: | $1.73M |
Gross Profit: | $1.06M (61.34 %) |
EPS: | $-0.260 |
Q2 | 2023 |
Revenue: | $1.60M |
Gross Profit: | $1.05M (65.54 %) |
EPS: | $-0.350 |
Financial Reports:
No articles found.
PROFOUND MEDICAL CORP
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators